By Liz Hoffman 

JPMorgan Chase & Co.'s health-care bankers in the past year worked on the $74 billion takeover of Celgene Corp. and the $62 billion sale of Shire PLC.

Last fall they pitched Cianna Medical, a California company with tumor-detecting technology and about $40 million in annual revenue, on a sale. "I kept saying, tell me again why you're interested in this deal?" said Jill Anderson, Cianna's then-chief executive.

Investment bankers across Wall Street are tripping over themselves, and sometimes each other, to win business advising smaller companies on deals -- assignments they would have scoffed at a few years ago. They are hiring bankers in cities like Dallas and Atlanta and cozying up to a different set of corporate executives.

A Goldman Sachs Group Inc. partner cold-called his way onto a $162 million stock-offering deal for a Texas-based chemicals company. Citigroup Inc. sent a chairman to pitch for a $140 million tech deal. Bank of America Corp. has doubled its investment bankers in regional offices over the past two years.

And JPMorgan beat out four other banks to represent Cianna, which sold for $200 million to Merit Medical Systems Inc.

"You worry as a CEO of a smaller company that you'll get the B team" from a big bank, said Ms. Anderson, now a Merit board member. "We didn't."

As the post-crisis deal boom shows signs of slowing, Wall Street firms accustomed to headline-grabbing megadeals are sliding downmarket. Deals between $500 million and a few billion dollars historically have been dominated by regional firms such as Harris Williams & Co. in Richmond, Va., and Minneapolis's Piper Jaffray Cos.

"Every 10 years or so, the big banks get the idea to move in," said Mark Brady, head of mergers and acquisitions at William Blair & Co., a Chicago-based firm where the average deal is $400 million. "As soon as there's a down-cycle, they disappear."

Bank executives say they are committed this time. Their own investors are demanding growth, and "there are only so many big transactions," Mr. Brady said. There were 135 deals in the U.S. last year valued at over $2 billion, versus 2,200 under, according to FactSet.

While fees in the middle market are smaller, they are typically split between fewer banks. Deals also close faster and require fewer staff than complex, trans-Atlantic takeovers.

An explosion in private equity also has brought order and sophistication to the middle market. Sleepy family-owned firms have been replaced by sponsor-backed companies eager to borrow, do deals and go public. There are 7,800 companies owned by private-equity firms, up 65% since 2010, according to the Milken Institute.

Banks also have their eyes on the $1 trillion in dry powder private-equity firms have to spend.

Goldman in 2016 created a 30-banker team to focus on private-equity deals, part of a broader effort to add 1,000 new corporate clients to its roster of about 8,000. A spokeswoman said that group's revenue rose 25% from 2017 to 2018. Goldman dispatched four partners to regional offices in Dallas, Seattle, Atlanta and Toronto and assigned a dedicated banker to hundreds of what it calls "lonely clients," which get little attention from New York bankers.

"There are lots and lots of companies that have enterprise values of $500 million to $3 billion that have just never been addressed by Goldman Sachs," Chief Executive David Solomon said earlier this year.

JPMorgan in 2012 created a new group to focus on regional deal-making. Investment bankers started pitching their services to the thousands of midsize companies that already used JPMorgan's commercial bank to manage their day-to-day finances.

Today the group includes 60 bankers across seven offices, working for Atlanta native John Richert. JPMorgan said it has doubled the investment-banking fees it collects from those commercial-banking clients, from $1.3 billion in 2010 to $2.5 billion last year.

"I tell my team, 'You're probably not going to be on the front page of The Wall Street Journal,'" Mr. Richert said. "'But you will be on the front page of the transaction summary that [JPMorgan CEO] Jamie [Dimon] gets on Friday mornings.'"

Joe Armes, chief executive of CSW Industrials Inc., an $870 million maker of industrial sealants and lubricants, said he hears monthly from Andy Rabin, JPMorgan's point man in Dallas. Aasem Khalil, a Goldman partner who relocated there in 2017, has visited CSW's offices three times in the past year, Mr. Armes said.

"There's none of that 'flyover state' mentality you sometimes get from New York bankers," Mr. Armes said.

Some banks are positioning the middle market as a way for younger bankers to prove themselves. But senior executives are pitching in, too.

When Ani Gadre decided to sell the software company he had founded in 1997, he was surprised when Ben Druskin, Citigroup's chairman of technology banking, came to his Fremont, Calif., offices to pitch. Citigroup beat out Credit Suisse Group AG and other big banks for the business, Mr. Gadre said. His company, eTouch Systems, sold for $140 million.

"I thought I'd be too small for them," said Mr. Gadre. He said he is planning a celebratory closing dinner, and Citigroup bankers have promised to pick up the tab.

Write to Liz Hoffman at liz.hoffman@wsj.com

 

(END) Dow Jones Newswires

April 01, 2019 22:18 ET (02:18 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Feb 2024 to Mar 2024 Click Here for more Celgene Charts.
Celgene (NASDAQ:CELG)
Historical Stock Chart
From Mar 2023 to Mar 2024 Click Here for more Celgene Charts.